Controlled Human Inhalation-Exposure Studies at EPA (2017)
Chapter: Appendix B: Public Information-Gathering Sessions
Appendix B
Public Information-Gathering Sessions
COMMITTEE ON ASSESSING TOXICOLOGIC RISKS TO HUMAN SUBJECTS USED IN CONTROLLED EXPOSURE STUDIES OF ENVIRONMENTAL POLLUTANTS
PUBLIC INFORMATION-GATHERING SESSION
June 1, 2015
National Academy of Sciences Building
2101 Constitution Avenue, NW
Washington, DC 20418
Opening Remarks from Robert Hiatt and Introduction of Committee Members
EPA Research Overview
Robert Kavlock (Deputy Assistant Administrator for Science, EPA/ORD)
Foundations of the NAS Charge: Ethical Issues in Foreseeable Risk,
Toby Schonfeld (Director, EPA Program in Human Research Ethics and Oversight; EPA Human Subjects Research Review Official)
Conduct, Process, and Outcomes of Exposure Studies,
Wayne Cascio (Director, Environmental Public Health Division, National Health Environmental Effects Research Laboratory, EPA/ORD)
David Diaz-Sanchez (Chief, Clinical Research Branch, National Health Environmental Effects Research Laboratory, EPA/ORD)
EPA Human Subjects Regulatory Requirements
Dan Nelson (Director, Human Research Protocol Office, National Health Environmental Effects Research Laboratory, EPA/ORD)
Summary and Wrap-Up
Toby Schonfeld
Questions from Committee
Opportunity for Public Comment
End of Session
PUBLIC INFORMATION-GATHERING SESSION
August 24, 2016
Webinar
Opening Remarks from Robert Hiatt (Committee Chair) and Introduction of Committee Members
Presentation from Steve Milloy
Publisher, JunkScience.com
Presentation from John Dunn
Civilian Faculty Emergency Medicine
Carl R. Darnall Army Medical Center
Presentation from Stanley Young
Fellow, American Statistical Association and the American Association
for the Advancement of Science
Questions from Committee
Opportunity for Public Comment
James Enstrom (UCLA and Scientific Integrity Institute)
Albert Donnay (Johns Hopkins Center for Sleep Disorders)
End of Session
